EPISODE · Aug 25, 2026 · 9 MIN
今天3分钟我们来聊聊从"保命"到"修复"：外泌体让坏死脑神经重新生长
from 源于细胞BioInsid的个人播客
本期播客详解全球首个胎盘干细胞外泌体治疗恶性大面积脑梗死的人体试验，拆解疗法优势、安全性数据、修复机制与现存局限，展望脑卒中治疗从保命到修复的全新可能。📚 参考文献：同种异体胎盘间充质干细胞外泌体治疗恶性大脑中动脉梗死的首个人体临床试验（单中心开放标签试验，5例患者，随访3个月），原文由用户提供，发表于国际期刊。外泌体脑内注射机制：抗凋亡（caspase-3/PARP）、神经再生（doublecortin/NeuN+）、血管再生、免疫调节（CD4+/CD8+ T细胞、树突状细胞）。水凝胶-外泌体缓释系统：可注射粘附水凝胶负载MSC-EVs，持续释放促进血管新生和神经功能恢复。前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊从"保命"到"修复"：外泌体让坏死脑神经重新生长
0:00
9:11
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 9 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on August 25, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!